• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma Inc (NQ: SILO )

    1.130 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Silo Pharma Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Reports Promising Results from Testing of Ketamine-Loaded Implant for Chronic Pain Relief
    Via Investor Brand Network
    Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
    From Silo Pharma, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Reports on FDA Pre-IND Meeting to Advance Development of Lead Program
    Via Investor Brand Network
    Exposures Product Safety
    Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Why Is Silo Pharma (SILO) Stock Up 60% Today?
    With developmental-stage Silo Pharma inking a partnership to forward PTSD drugs, SILO stock shot higher on the credibility boost. 
    Via InvestorPlace
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant Therapeutic
    Via Investor Brand Network
    Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Agreement to Launch New Study of SPU-16 Homing Peptide for Multiple Sclerosis
    Via Investor Brand Network
    Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
    From Silo Pharma, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) to Participate in Upcoming H.C. Wainwright Annual Global Investment Conference
    Via Investor Brand Network
    Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Crude Oil Down 3%; Netflix Earnings Top Estimates
    Via Benzinga
    Exposures Fossil Fuels
    Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Enters into $2.1M Registered Direct Offering
    Via Investor Brand Network
    Gold Down 2%; SLB Posts Upbeat Earnings
    Via Benzinga
    Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug
    Silo Pharma stock soared on high trading volume after announcing a partnership with Resyca BV for developing an intranasal PTSD treatment. The collaboration aims to enhance drug delivery to the brain,... 
    Via Benzinga
    Dow Dips 250 Points; US Weekly Jobless Claims Surge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Enters Device and CMC Development Master Plan to Support IND-Enabling Study of SPC-15
    Via Investor Brand Network
    US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
    Via Benzinga
    Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
    Via Benzinga
    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
    Via Investor Brand Network
    Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
    Silo Pharma shares surge due to a global license agreement for Alzheimer's drug SPC-14, aiming to utilize the FDA's 505(b)(2) pathway. SPC-14 shows promise in stress reduction and cognitive... 
    Via Benzinga
    Exposures Product Safety
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.